Related Experiment Video
Updated: Jul 7, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
[Experimental animal research in the EU legislation]
1Stiftung für das Tier im Recht, CH-Zürich. gieri.bo@bluewin.ch
ALTEX
|July 4, 2002
Summary
European Union legislation partially covers animal research, focusing on market harmonization rather than comprehensive animal protection. Current guidelines require expansion and updates to better safeguard animals in all research areas.
Area of Science:
- Animal research legislation
- European Union law
- Comparative animal welfare policy
Context:
- EU legislation on experimental animal research is fragmented.
- The primary goal of guideline 86/609/EWG is market harmonization, not animal protection.
- National regulations vary significantly, creating inconsistencies.
Purpose:
- To analyze the scope and limitations of current EU legislation on animal experimentation.
- To identify areas where EU animal research laws fall short of comprehensive protection.
- To propose improvements for more effective animal welfare standards at the EU level.
Summary:
- Current EU legislation, particularly guideline 86/609/EWG, inadequately covers experimental animal research.
- The guideline prioritizes economic harmonization over robust animal welfare, with limited scope (vertebrates, applied research).
- Key areas like basic research, education, and defense-related studies are excluded from common regulation.
Impact:
- The existing framework allows considerable national discretion, leading to uneven animal protection.
- There is a need to broaden the scope and update the guideline to reflect scientific advancements.
- Integrating animal protection into EU policy goals is crucial for comprehensive regulation.
Related Concept Videos
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...